Though certain broad-spectrum HDAC inhibitors are currently being utilized for the treatment of cancers (Vorinostat/SAHA), the mechanism of action for HDAC inhibitors as cancer therapeutics is not completely clear. Here, HDAC9 is linked to cancer.